Does Obesity Modify the Ability of Prebiopsy Prostate Specific Antigen to Detect Prostate Cancer on Repeat Biopsy? Results from the REDUCE Study

作者: Adriana C. Vidal , Lauren E. Howard , Daniel M. Moreira , Ramiro Castro-Santamaria , Gerald L. Andriole

DOI: 10.1016/J.JURO.2015.01.111

关键词: DutasterideBody mass indexBiopsyUrologyObesityMedicineProstate cancerPCA3Prostate-specific antigenOverweightOncologyInternal medicine

摘要: Purpose: Higher body mass index is linked to lower prostate specific antigen. This has given rise concerns that antigen may be less reliable for predicting cancer among obese men. We tested the accuracy of prebiopsy across categories.Materials and Methods: used REDUCE study, which dutasteride risk reduction in men with a 2.5 to 10.0 ng/ml negative pre-study biopsy. All were required have biopsy at 2 4 years independent assessed performance predict overall high grade (Gleason sum 7 or greater) each group using AUC.Results: Of 6,103 who had 2-year 1,646 (27%) normal weight, 3,209 (53%) overweight 1,248 (20%) obese. Mean adjusted overw...

参考文章(30)
Yasuaki Kubota, Kensaku Seike, Shinichi Maeda, Yuka Shinohara, Masamitsu Iwata, Norio Sugimoto, Relationship between prostate-specific antigen and obesity in prostate cancer screening: Analysis of a large cohort in Japan International Journal of Urology. ,vol. 18, pp. 72- 75 ,(2011) , 10.1111/J.1442-2042.2010.02667.X
Jong J. Oh, Seong J. Jeong, Byung K. Lee, Chang W. Jeong, Seok-Soo Byun, Sung K. Hong, Sang E. Lee, Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy BJU International. ,vol. 112, pp. E265- E271 ,(2013) , 10.1111/J.1464-410X.2012.11766.X
Constanza López Fontana, Rafael Pérez Elizalde, José Daniel López Laur, Pablo Corica Alberto, Nicolás Di Milta, María Eugenia Maselli, LA OBESIDAD MODIFICA EL ANTÍGENO PROSTÁTICO ESPECÍFICO EN HOMBRES MAYORES DE 45 AÑOS DE EDAD Archivos españoles de urología. ,vol. 64, pp. 35- 42 ,(2011)
Al Baha Barqawi, Brian K. Golden, Colin O’Donnell, Michael K. Brawer, E. David Crawford, Observed effect of age and body mass index on total and complexed PSA: Analysis from a national screening program Urology. ,vol. 65, pp. 708- 712 ,(2005) , 10.1016/J.UROLOGY.2004.10.074
Adriana C. Vidal, Lauren E. Howard, Daniel M. Moreira, Ramiro Castro-Santamaria, Gerald L. Andriole, Stephen J. Freedland, Obesity Increases the Risk for High-Grade Prostate Cancer: Results from the REDUCE Study Cancer Epidemiology, Biomarkers & Prevention. ,vol. 23, pp. 2936- 2942 ,(2014) , 10.1158/1055-9965.EPI-14-0795
Jacques Baillargeon, Brad H. Pollock, Alan R. Kristal, Patrick Bradshaw, Javier Hernandez, Joseph Basler, Betsy Higgins, Steve Lynch, Thomas Rozanski, Dean Troyer, Ian Thompson, The association of body mass index and prostate-specific antigen in a population-based study. Cancer. ,vol. 103, pp. 1092- 1095 ,(2005) , 10.1002/CNCR.20856
Niyati Parekh, Yong Lin, Robert S. DiPaola, Stephen Marcella, Grace Lu-Yao, Obesity and prostate cancer detection: Insights from three national surveys The American Journal of Medicine. ,vol. 123, pp. 829- 835 ,(2010) , 10.1016/J.AMJMED.2010.05.011
Jennifer L. Beebe-Dimmer, Gary J. Faerber, Hal Morgenstern, David Werny, Kirk Wojno, Bronwen Halstead-Nussloch, Kathleen A. Cooney, Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study. Urology. ,vol. 71, pp. 554- 560 ,(2008) , 10.1016/J.UROLOGY.2007.11.049
Hans Lilja, David Ulmert, Andrew J. Vickers, Prostate-specific antigen and prostate cancer: prediction, detection and monitoring Nature Reviews Cancer. ,vol. 8, pp. 268- 278 ,(2008) , 10.1038/NRC2351
Roberto L. Muller, Leah Gerber, Daniel M. Moreira, Gerald Andriole, Ramiro Castro-Santamaria, Stephen J. Freedland, Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial. European Urology. ,vol. 62, pp. 757- 764 ,(2012) , 10.1016/J.EURURO.2012.05.025